DK0810877T3 - Hepatitis B-vaccine - Google Patents

Hepatitis B-vaccine

Info

Publication number: DK0810877T3
Authority: DK; Denmark
Prior art keywords: vaccine; hepatitis
Prior art date: 1995-02-25

Application number

DK96904814T

Other languages

English (en)

Inventor

Pierre Hauser

Nathalie Marie-Josephe Garcon

Pierre Desmons

Original Assignee

Smithkline Beecham Biolog

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1995-02-25

Filing date

1996-02-15

Publication date

2002-02-25

Family has litigation

First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=10770292&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=DK0810877(T3) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.

1996-02-15 Application filed by Smithkline Beecham Biolog filed Critical Smithkline Beecham Biolog

2002-02-25 Application granted granted Critical

2002-02-25 Publication of DK0810877T3 publication Critical patent/DK0810877T3/da

Links

SPSXSWRZQFPVTJ-ZQQKUFEYSA-N hepatitis b vaccine Chemical compound C([C@H](NC(=O)[C@H]([C@@H](C)O)NC(=O)[C@H]([C@@H](C)O)NC(=O)[C@H](CO)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CC=1C2=CC=CC=C2NC=1)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@@H](N)CCSC)C(=O)N[C@@H](CC1N=CN=C1)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC(O)=O)C(=O)N1[C@@H](CCC1)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](C(C)C)C(=O)OC(=O)CNC(=O)CNC(=O)[C@H](C)NC(=O)[C@H]1N(CCC1)C(=O)[C@H](CC=1C=CC=CC=1)NC(=O)[C@H](CC=1C=CC(O)=CC=1)NC(=O)[C@H](CC(C)C)NC(=O)CNC(=O)[C@@H](N)CCCNC(N)=N)C1=CC=CC=C1 SPSXSWRZQFPVTJ-ZQQKUFEYSA-N 0.000 title 1
229940124736 hepatitis-B vaccine Drugs 0.000 title 1

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/39—Medicinal preparations containing antigens or antibodies characterised by the immunostimulating additives, e.g. chemical adjuvants
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/12—Viral antigens
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/12—Viral antigens
- A61K39/29—Hepatitis virus
- A61K39/292—Serum hepatitis virus, hepatitis B virus, e.g. Australia antigen
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/20—Antivirals for DNA viruses
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
- A61K2039/55505—Inorganic adjuvants
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
- A61K2039/55511—Organic adjuvants
- A61K2039/55572—Lipopolysaccharides; Lipid A; Monophosphoryl lipid A
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2730/00—Reverse transcribing DNA viruses
- C12N2730/00011—Details
- C12N2730/10011—Hepadnaviridae
- C12N2730/10111—Orthohepadnavirus, e.g. hepatitis B virus
- C12N2730/10134—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Chemical & Material Sciences (AREA)
Virology (AREA)
Medicinal Chemistry (AREA)
Veterinary Medicine (AREA)
Public Health (AREA)
General Health & Medical Sciences (AREA)
Animal Behavior & Ethology (AREA)
Pharmacology & Pharmacy (AREA)
Mycology (AREA)
Immunology (AREA)
Epidemiology (AREA)
Microbiology (AREA)
Chemical Kinetics & Catalysis (AREA)
General Chemical & Material Sciences (AREA)
Communicable Diseases (AREA)
Oncology (AREA)
Organic Chemistry (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Biotechnology (AREA)
Molecular Biology (AREA)
Engineering & Computer Science (AREA)
Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
Peptides Or Proteins (AREA)
Micro-Organisms Or Cultivation Processes Thereof (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Medicinal Preparation (AREA)

DK96904814T 1995-02-25 1996-02-15 Hepatitis B-vaccine DK0810877T3 (da)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
GBGB9503863.4A GB9503863D0 (en)	1995-02-25	1995-02-25	Vaccine compositions
PCT/EP1996/000681 WO1996026741A1 (en)	1995-02-25	1996-02-15	Hepatitis b vaccine

Publications (1)

Publication Number	Publication Date
DK0810877T3 true DK0810877T3 (da)	2002-02-25

Family

ID=10770292

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
DK96904814T DK0810877T3 (da)	1995-02-25	1996-02-15	Hepatitis B-vaccine

Country Status (35)

Country	Link
US (1)	US5972346A (da)
EP (1)	EP0810877B1 (da)
JP (1)	JP3881015B2 (da)
KR (1)	KR100365373B1 (da)
CN (1)	CN1101225C (da)
AP (1)	AP766A (da)
AR (1)	AR002279A1 (da)
AT (1)	ATE209045T1 (da)
AU (1)	AU695921B2 (da)
BG (1)	BG101851A (da)
BR (1)	BR9607458A (da)
CA (1)	CA2212552C (da)
CZ (1)	CZ288417B6 (da)
DE (1)	DE69617211T2 (da)
DK (1)	DK0810877T3 (da)
EA (1)	EA199700126A1 (da)
ES (1)	ES2166879T3 (da)
FI (1)	FI118118B (da)
GB (1)	GB9503863D0 (da)
HU (1)	HU224832B1 (da)
IL (1)	IL117249A (da)
MA (1)	MA23814A1 (da)
MX (1)	MX9706450A (da)
MY (1)	MY113428A (da)
NO (1)	NO319394B1 (da)
NZ (1)	NZ302674A (da)
OA (1)	OA10612A (da)
PL (1)	PL182679B1 (da)
PT (1)	PT810877E (da)
SA (1)	SA96160633B1 (da)
SK (1)	SK115097A3 (da)
TR (1)	TR199700849T1 (da)
TW (1)	TW467745B (da)
WO (1)	WO1996026741A1 (da)
ZA (1)	ZA961460B (da)

Families Citing this family (40)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US6620414B2 (en) *	1992-03-27	2003-09-16	Smithkline Beecham Biologicals (S.A.)	Hepatitis vaccines containing 3-0-deacylated monophoshoryl lipid A
FR2711670B1 (fr)	1993-10-22	1996-01-12	Pasteur Institut	Vecteur nucléotidique, composition le contenant et vaccin pour l'immunisation à l'encontre d'une hépatite.
US6488934B1 (en) *	1995-02-25	2002-12-03	Smithkline Beecham Biologicals S.A.	Hepatitis B vaccine
US20010014331A1 (en) *	1996-11-07	2001-08-16	Smithkline Beecham Biologicals S.A.	Acellular pertussis vaccine with diphthriae-and tetanus-toxoids
US20030049268A1 (en)	1998-05-01	2003-03-13	Smithkline Beecham Biologicals S.A.	Novel composition
GB9809507D0 (en) *	1998-05-01	1998-07-01	Smithkline Beecham Biolog	Novel composition
PT1077722E (pt)	1998-05-22	2006-12-29	Coley Pharm Group Inc	Produtos e composições para utilização na indução da imunidade mucosal
US6306404B1 (en)	1998-07-14	2001-10-23	American Cyanamid Company	Adjuvant and vaccine compositions containing monophosphoryl lipid A
DE69935606T9 (de)	1998-10-16	2021-03-11	Glaxosmithkline Biologicals S.A.	Adjuvanzsysteme und impfstoffe
CU22871A1 (es) *	1998-12-02	2003-10-21	Ct Ingenieria Genetica Biotech	Formulaciones conteniendo partículas semejantes a virus como inmunopotenciadores por vía mucosal
CA2355680A1 (en) *	1998-12-23	2000-06-29	Qinjian Zhao	Improved recombinant hepatitis b surface antigen
DE60014076T2 (de)	1999-04-19	2005-10-13	Glaxosmithkline Biologicals S.A.	Adjuvans-zusammensetzung, enthaltend saponin und ein immunstimulatorisches oligonukleotid
US6635261B2 (en)	1999-07-13	2003-10-21	Wyeth Holdings Corporation	Adjuvant and vaccine compositions containing monophosphoryl lipid A
CU23031A1 (es) *	2002-01-24	2005-02-23	Ct Ingenieria Genetica Biotech	Antigeno de superficie del virus de la hepatitis b como inmunopotenciador mucosal, formulaciones resultantes
US20090214592A1 (en) *	2005-02-16	2009-08-27	O'hagan Derek	Adjuvant composition comprising aluminium phosphate and 3D-MPL
ATE526036T1 (de) *	2005-08-02	2011-10-15	Novartis Vaccines & Diagnostic	Reduzierung der interferenz zwischen ölhaltigen adjuvanzien und surfactanthaltigen antigenen
ES2420829T3 (es)	2005-11-04	2013-08-27	Novartis Vaccines And Diagnostics S.R.L.	Vacunas adyuvantadas con antígeno de no virión preparadas a partir de virus de la gripe cultivados en cultivo celular
NZ568211A (en)	2005-11-04	2011-11-25	Novartis Vaccines & Diagnostic	Influenza vaccines including combinations of particulate adjuvants and immunopotentiators
US20090304742A1 (en)	2005-11-04	2009-12-10	Novartis Vaccines And Diagnostics Srl	Influenza vaccines with reduced amount of emulsion adjuvant
EP1951298A1 (en)	2005-11-04	2008-08-06	Novartis Vaccines and Diagnostics S.r.l.	Adjuvanted influenza vaccines including cytokine-inducing agents
CN100415294C (zh) *	2005-12-23	2008-09-03	中国农业大学	一种治疗和/或预防乙肝的药物
EP3753574A1 (en)	2006-01-27	2020-12-23	Seqirus UK Limited	Influenza vaccines containing hemagglutinin and matrix proteins
CA2646539A1 (en)	2006-03-23	2007-09-27	Novartis Ag	Imidazoquinoxaline compounds as immunomodulators
EP2004226A1 (en)	2006-03-24	2008-12-24	Novartis Vaccines and Diagnostics GmbH & Co. KG	Storage of influenza vaccines without refrigeration
EP1862176A1 (de) *	2006-05-31	2007-12-05	Rhein Biotech Gesellschaft für neue biotechnologische Prozesse und Produkte mbH	Ein Verfahren zur Herstellung einer Impfzusammensetzung
EP1862177A1 (de) *	2006-06-01	2007-12-05	Rhein Biotech Gesellschaft für neue biotechnologische Prozesse und Produkte mbH	Ein Verfahren zur Herstellung einer Impfzusammensetzung
DK2054431T3 (da)	2006-06-09	2012-01-02	Novartis Ag	Konformere af bakterielle adhæsiner
GB0614460D0 (en)	2006-07-20	2006-08-30	Novartis Ag	Vaccines
ES2536401T3 (es)	2006-09-11	2015-05-25	Novartis Ag	Fabricación de vacunas contra virus de la gripe sin usar huevos
SG177141A1 (en)	2006-12-06	2012-01-30	Novartis Ag	Vaccines including antigen from four strains of influenza virus
EA201070066A1 (ru)	2007-06-27	2010-06-30	Новартис Аг	Вакцины против гриппа с низким содержанием добавок
GB0810305D0 (en)	2008-06-05	2008-07-09	Novartis Ag	Influenza vaccination
GB0818453D0 (en)	2008-10-08	2008-11-12	Novartis Ag	Fermentation processes for cultivating streptococci and purification processes for obtaining cps therefrom
AU2008339631B2 (en)	2007-12-24	2014-07-24	Novartis Ag	Assays for adsorbed influenza vaccines
EP4218799A1 (en)	2009-07-15	2023-08-02	GlaxoSmithKline Biologicals S.A.	Rsv f protein compositions and methods for making same
AU2012211278B2 (en)	2011-01-26	2016-11-10	Glaxosmithkline Biologicals Sa	RSV immunization regimen
US9452212B2 (en)	2011-04-14	2016-09-27	Dynavax Technologies Corporation	Methods and compositions for eliciting an immune response against hepatitis B virus
DK2707385T3 (da)	2011-05-13	2017-11-20	Glaxosmithkline Biologicals Sa	RSV-F-præfusionsantigener
HK1254344A1 (zh)	2015-06-26	2019-07-19	Seqirus UK Limited	抗原匹配的流感疫苗
CN118987191A (zh)	2018-11-13	2024-11-22	变异生物技术公司	用于治疗乙型肝炎的免疫原性组合物

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US4912094B1 (en) *	1988-06-29	1994-02-15	Ribi Immunochem Research Inc.	Modified lipopolysaccharides and process of preparation
DK0414374T3 (da) *	1989-07-25	1998-03-09	Smithkline Beecham Biolog	Hidtil ukendte antigener og fremgangsmåder til fremstilling deraf
WO1992021292A2 (en) *	1991-05-29	1992-12-10	Origin Medsystems, Inc.	Retraction apparatus and methods for endoscopic surgery
MA22842A1 (fr) *	1992-03-27	1993-10-01	Smithkline Beecham Biolog	Procede de preparation de compositions de vaccin.
FI945483A7 (fi) *	1992-05-23	1995-01-20	Smithkline Beecham Biologicals S A	Hepatiitti B - pinta-antigeenejä ja muita antigeenejä sisältäviä yhdistelmärokotteita
ATE157882T1 (de) *	1993-03-23	1997-09-15	Smithkline Beecham Biolog	3-0-deazylierte monophosphoryl lipid a enthaltende impfstoff-zusammensetzungen
GB9311536D0 (en) *	1993-06-04	1993-07-21	Unilever Plc	Hot soluble low density extractable food product

1995
- 1995-02-25 GB GBGB9503863.4A patent/GB9503863D0/en active Pending
1996
- 1996-02-14 MY MYPI96000567A patent/MY113428A/en unknown
- 1996-02-15 AU AU48780/96A patent/AU695921B2/en not_active Ceased
- 1996-02-15 JP JP52598896A patent/JP3881015B2/ja not_active Expired - Fee Related
- 1996-02-15 ES ES96904814T patent/ES2166879T3/es not_active Expired - Lifetime
- 1996-02-15 US US08/894,643 patent/US5972346A/en not_active Expired - Lifetime
- 1996-02-15 CA CA002212552A patent/CA2212552C/en not_active Expired - Fee Related
- 1996-02-15 TR TR97/00849T patent/TR199700849T1/xx unknown
- 1996-02-15 PT PT96904814T patent/PT810877E/pt unknown
- 1996-02-15 AT AT96904814T patent/ATE209045T1/de active
- 1996-02-15 KR KR1019970705880A patent/KR100365373B1/ko not_active Expired - Fee Related
- 1996-02-15 EA EA199700126A patent/EA199700126A1/ru unknown
- 1996-02-15 SK SK1150-97A patent/SK115097A3/sk unknown
- 1996-02-15 NZ NZ302674A patent/NZ302674A/xx not_active IP Right Cessation
- 1996-02-15 BR BR9607458A patent/BR9607458A/pt not_active IP Right Cessation
- 1996-02-15 DK DK96904814T patent/DK0810877T3/da active
- 1996-02-15 DE DE69617211T patent/DE69617211T2/de not_active Expired - Lifetime
- 1996-02-15 AP APAP/P/1997/001060A patent/AP766A/en active
- 1996-02-15 EP EP96904814A patent/EP0810877B1/en not_active Expired - Lifetime
- 1996-02-15 CN CN96192146A patent/CN1101225C/zh not_active Expired - Fee Related
- 1996-02-15 WO PCT/EP1996/000681 patent/WO1996026741A1/en not_active Ceased
- 1996-02-15 PL PL96321966A patent/PL182679B1/pl unknown
- 1996-02-15 CZ CZ19972674A patent/CZ288417B6/cs not_active IP Right Cessation
- 1996-02-15 HU HU9801242A patent/HU224832B1/hu not_active IP Right Cessation
- 1996-02-22 AR ARP960101469A patent/AR002279A1/es active IP Right Grant
- 1996-02-23 IL IL11724996A patent/IL117249A/xx not_active IP Right Cessation
- 1996-02-23 MA MA24171A patent/MA23814A1/fr unknown
- 1996-02-23 ZA ZA961460A patent/ZA961460B/xx unknown
- 1996-02-26 TW TW085102154A patent/TW467745B/zh not_active IP Right Cessation
- 1996-03-02 SA SA96160633A patent/SA96160633B1/ar unknown
1997
- 1997-08-02 OA OA70066A patent/OA10612A/en unknown
- 1997-08-22 MX MX9706450A patent/MX9706450A/es unknown
- 1997-08-22 NO NO19973873A patent/NO319394B1/no not_active IP Right Cessation
- 1997-08-22 FI FI973457A patent/FI118118B/fi not_active IP Right Cessation
- 1997-08-25 BG BG101851A patent/BG101851A/xx unknown

Also Published As

Publication number	Publication date
WO1996026741A1 (en)	1996-09-06
ATE209045T1 (de)	2001-12-15
NZ302674A (en)	1999-01-28
CZ288417B6 (en)	2001-06-13
CN1101225C (zh)	2003-02-12
CZ267497A3 (cs)	1998-02-18
BR9607458A (pt)	1998-06-30
PL182679B1 (pl)	2002-02-28
MY113428A (en)	2002-02-28
AU4878096A (en)	1996-09-18
NO319394B1 (no)	2005-08-08
JPH11501018A (ja)	1999-01-26
TW467745B (en)	2001-12-11
US5972346A (en)	1999-10-26
HU224832B1 (en)	2006-03-28
BG101851A (en)	1998-04-30
SA96160633B1 (ar)	2005-10-15
IL117249A (en)	2000-11-21
HUP9801242A3 (en)	2000-08-28
FI973457A0 (fi)	1997-08-22
HK1004117A1 (en)	1998-11-20
PL321966A1 (en)	1998-01-05
KR19980702480A (ko)	1998-07-15
AP766A (en)	1999-09-17
CA2212552C (en)	2006-07-11
NO973873L (no)	1997-08-22
OA10612A (en)	2002-08-29
TR199700849T1 (xx)	1998-01-21
JP3881015B2 (ja)	2007-02-14
MX9706450A (es)	1998-07-31
DE69617211T2 (de)	2002-07-25
AU695921B2 (en)	1998-08-27
CA2212552A1 (en)	1996-09-06
FI118118B (fi)	2007-07-13
EP0810877A1 (en)	1997-12-10
EP0810877B1 (en)	2001-11-21
IL117249A0 (en)	1996-06-18
AR002279A1 (es)	1998-03-11
GB9503863D0 (en)	1995-04-19
DE69617211D1 (en)	2002-01-03
FI973457L (fi)	1997-08-22
AP9701060A0 (en)	1997-10-31
MA23814A1 (fr)	1996-10-01
ZA961460B (en)	1996-08-29
SK115097A3 (en)	1998-02-04
PT810877E (pt)	2002-04-29
KR100365373B1 (ko)	2003-07-07
ES2166879T3 (es)	2002-05-01
NO973873D0 (no)	1997-08-22
HUP9801242A1 (hu)	1998-08-28
CN1176604A (zh)	1998-03-18
EA199700126A1 (ru)	1998-02-26

Publication	Publication Date	Title
DK0810877T3 (da)	2002-02-25	Hepatitis B-vaccine
NO976060D0 (no)	1997-12-23	Vaksiner mot hepatitt C
NO20003302D0 (no)	2000-06-23	Vaksine
KR970704468A (ko)	1997-09-06	폴리에피토프 백신(polyepitope vaccines)
BR9711853A (pt)	1999-08-24	Vacinas
ID20399A (id)	1998-12-10	Vaksin influensa
DE69126606D1 (de)	1997-07-24	Vakzine
DK0736303T3 (da)	2000-01-10	Interferonopløsning
FI944052A7 (fi)	1994-09-02	Oraalinen rokote
EP0967993A4 (en)	2001-04-18	ANTI-COCAINE VACCINE
DK0863991T3 (da)	2004-02-09	Antigeniske præparater
DE69509766D1 (de)	1999-06-24	Mikroemulsionen
DE69628167D1 (de)	2003-06-18	Spezifische oligonukleotide fuer hepatitis c-virus
IT1276662B1 (it)	1997-11-03	Vaccini polinucleotidici
FI973755A7 (fi)	1997-10-14	Viistokantaniitti
NO933600D0 (no)	1993-10-08	Termostabile virus
ITMI950511A0 (it)	1995-03-16	Fotodensitometro parallelo perfezionato
NO980721D0 (no)	1998-02-20	Vaksiner
SI0810877T1 (en)	2002-06-30	Hepatitis b vaccine
DE69326536D1 (de)	1999-10-28	Antitumor Impfstoff
FI944558A0 (fi)	1994-09-30	Virus
UA24703A (uk)	1998-10-30	Емітерний повторювач
BR7502544U (pt)	1998-05-05	Easy baby
KR970703417A (ko)	1997-07-03	유두종 바이러스 백신(Papillomavirus vaccines)
BR7500363U (pt)	1995-06-13	Formulário